BBIO (NASDAQ) Form 144 shows proposed sale of 83,088 shares and RSUs
Rhea-AI Filing Summary
BBIO reported proposed sales of Common Stock via Form 144. The filing lists a stock option exercise tied to 83,088 shares dated 06/15/2026 with cash as the consideration method, and two restricted stock lots of 3,576 shares each dated 11/16/2020 and 11/16/2021. The entries are presented as securities to be sold by the reporting holder through the issuer pathway.
Positive
- None.
Negative
- None.
Insights
Form 144 lists proposed resale activity tied to option exercise and restricted stock lots.
The filing shows a stock option exercise associated with 83,088 shares on 06/15/2026, and two restricted stock entries of 3,576 shares each (dated 11/16/2020 and 11/16/2021.
These lines reflect the holder's intent to sell under Form 144 reporting rules; actual sales, timing, and cash‑flow recipients are not detailed in the excerpt. Subsequent transfer or sale filings would confirm execution and settlement.
Key Figures
Key Terms
Form 144 regulatory
Stock Option Exercise financial
Restricted Stock financial
Issuer pathway regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.